701
Views
46
CrossRef citations to date
0
Altmetric
Papers

Effects of non-fermented and fermented soybean milk intake on faecal microbiota and faecal metabolites in humans

, , , , &
Pages 402-410 | Published online: 01 Nov 2011

References

  • Adlercreutz H. 1998. Epidemiology of phytoestrogens Baillière's. Clin Endocrinol Metab. 12:605–623.
  • Anderson JJB, Anthony M, Meessina M, Garner SC. 1999. Effects of phyto-oestrogens on tissues. Nutr Res Rev. 12:75–116.
  • Benno Y, Endo K, Shiragami N, Sayama K, Mitsuoka T. 1987. Effects of raffinose intake on human fecal microflora. Bifidobacteria Microflora. 6:59–63.
  • Benno Y, Endo K, Mizutani T, Namba Y, Komori T, Mitsuoka T. 1989. Comparison of fecal microflora of elderly persons in rural and urban areas of Japan. Appl Environ Microbiol. 55:1100–1105.
  • Buddington RK, Williams CH, Chen SC, Witherly SA. 1996. Dietary supplementation of neosugar alters the fecal and decreases activities of some reductive enzymes in human subjects. Am J Clin Nutr. 63:709–716.
  • Delcenserie V, Martel D, Lamoureux M, Amiot J, Boutin Y, Roy D. 2008. Immunomodulatory effects of probiotics in the intestinal tract. Curr Issues Mol Biol. 10:37–54.
  • Dunne C. 2001. Adaptation of bacteria to the intestinal niche: probiotics and gut disorder. Inflamm Bowel Dis. 7:136–145.
  • Fujisawa T, Shinohara K, Kishimoto Y, Terada A. 2006. Effect of miso soup containing Natto on the composition and metabolic activity of the human faecal flora. Microbiol Ecol Health Dis. 16:79–84.
  • Fukushima Y, Shou-tou L, Hara H, Terada A, Mitsuoka T. 1997. Effect of follow-up formula containing bifidobacteria (NAN BF) on fecal flora and fecal metabolites in healthy children. Biosci Microflora. 16:65–72.
  • Fuller R. 1989. Probiotics in man and animals. J Appl Bacteriol. 66:365–378.
  • Gibons GR, Beatry EB, Wang X, Cummings JH. 1995. Selective stimulation of bifidobacteria in the human colon by oligo-fructose and inulin. Gastroenterol. 108:975–982.
  • Gibson GR, Roberfroid MB. 1995. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 125:1401–1412.
  • Hara H, Li ST, Sasaki M, Maruyama T, Terada A, Ogata Y, . 1994. Effective dose of lactosucrose on fecal flora and fecal metabolites of humans. Bifidobacteria Microflora. 13:51–63.
  • Hayakawa K, Mizutani J, Wada K, Masai T, Yoshihara I, Mitsuoka T. 1990. Effects of soybean oligosaccharides on human faecal flora. Microbiol Ecol Health Dis. 3:293–303.
  • Isolauri E, Salminen S, Ouwehand AC. 2004. Probiotics. Best Pract Res Clin Gastroentel. 18:299–313.
  • Karyadi D, Lukito W. 1996. Beneficial effects of tempeh in disease prevention and treatment. Nutr Rev. 54:S94–S98.
  • Kries JL, Nout MJR, Rombouts FM, Nabuurs MJA, van der Meulen J. 2002. Inhibition of adhesion of enterotoxigenic Escherichia coli K88 by soya bean tempe. Lett Appl Microbiol. 35:311–315.
  • Kurmann JA, Rašić JLJ. 1991. The health potential of products containing bifidobacteria. In: Robinson RK. editors. Therapeutic properties of fermented milks. London: Elsevier Applied Science117–157.
  • Ley RE, Turnbaugh PJ, Klein S, Gordon JI. 2006. Microbial ecology:humnan gut microbes associated with obesty. Nature. 444:1022–1023.
  • Ljungh Å, Wadström T. 2006. Lactic acid bacteria as probiotics. Curr Issues Intest Microbiol. 7:73–90.
  • Marteau PR, de Vrese M, Cellier CJ, Schrezenmeir J. 2001. Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr. 73:430S–436S.
  • Masaoka Y, Watanabe H, Katoh O, Ito A, Doi K. 1998. Effects of miso and NaCl on the development of colonic aberrant cryptofoci induced by azoxymethane in F344 rats. Nutr Cancer. 32:25–28.
  • Matsuki T, Watanabe K, Tanaka R, Fukuda M, Oyaizu H. 1999. Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl Environ Microbiol. 65:4506–4512.
  • Matsumoto M, Imai T, Hironaka T, Kume H, Watanabe M, Benno Y. 2001. Effect of yogurt with Bifidobacterium lactis LKM512 in improving fecal microflora and defecation of healthy volunteers. J Intest Microbiol. 14:97–102 (in Japanese with English summary).
  • Messina MJ, Persky V, Setchell KDR, Barnes S. 1994. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer. 21:113–131.
  • Mitsuoka T. 2000. Significance of dietary modulation of intestinal flora and intestinal environment. Biosci Microflora. 19:15–25.
  • Mitsuoka T, Sega T, Yamamoto S. 1965. Eine verbesserte Methodik der qualitativen und quantitativen Analyse der Darmflora von Menschen und Tieren. Zentralbl Bakteriol Hyg Orig. 195:455–469.
  • Mitsuoka T, Ohno K, Benno Y, Suzuki K, Namba K. 1976. Die Faekalflora bei Menschen. IV. Mitteilung: Vergleich des neu entwickelten Verfahrens mit dem bisherigen üblichen Verfahren zur Darmfloraanalyse. Zentralbl Bakteriol Hyg Abt Orig. A234:219–233.
  • Nagura T, Muraguchi H, Uchino K, Aritsuka T, Benno Y. 1999. Effects of ingestion of raffinose-rich soup on the fecal flora and daily defecation in humans. J Intest Microbiol. 13:1–7 (in Japanese with English summary).
  • Narai-Kanayama A, Tokita N, Aso K. 2007. Dependence of fructooligosaccharide content on activity of fructooligosaccharide- metabolizing enzymes in yacon (Smallanthus sonchifolius) tuberous roots during storage. J Food Sci. 72:S381–S387.
  • Nout MJR, Kiers JL. 2005. Tempe fermentation, innovation and functionality: update into the third millenium. J Appl Microbiol. 98:789–805.
  • Nout MJR, Rombouts FM. 1990. Recent developments in tempe research. J Appl Bacteriol. 69:609–633.
  • Ohara M, Lu H, Shiraki K, Ishimura Y, Uesaki T, Katoh O, Watanabe H. 2002. Prevention by long-term fermented miso of induction of colonic aberrant crypt foci by azoxymethane in F344 rats. Oncol Rep. 9:69–73.
  • Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, . 2006. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics. 118:511–521.
  • Rowland IR, Mallett AK, Wise A. 1985. The effect of diet on the mammalian gut flora and its metabolic activities. CRC Crit Rev Toxicol. 16:31–103.
  • Sakai K, Tachiki T, Kumagai H, Tochikura T. 1987. Hydrolysis of β-d-galactosyl oligosaccharides in soymilk by β-d-galactosidase of Bifidobacterium breve 203. Agric Biol Chem. 51:315–322.
  • Takiguchi R, Miyamoto M, Mochizuki E, Suzuki Y, Kageyama R, Iino H. 1998. Effects of fermented-milk administration on defecation and fecal microflora of healthy volunteers. J Intest Microbiol. 11:117–122 (in Japanese with English summary).
  • Terada A, Hara H, Ikegame K, Sasaki M, Mitsuoka T. 1994. Recommended method for enumeration of lecithinase-positive clostridia in human feces. Bifidobacteria Microflora. 13:27–30.
  • Terada A, Hara H, Sato D, Higashi T, Nakayama S, Tsuji K, . 1995. Effect of dietary chitosan on faecal microbiota and faecal metabolites of humans. Microbiol Ecol Health Dis. 8:15–21.
  • Terada A, Yamamoto M, Yoshimura E. 1999. Effect of the fermented soybean product “Natto” on the composition and metabolic acitivity of the human fecal flora. Jpn J Food Microbiol. 16:221–230.
  • Wada K, Mizutani J, Watabe J, Suzuki H, Shirayanagi S. 1991. Effects of soybean oligosaccharides intake on fecal microflora. Bifidus. 5:51–54 (in Japanese with English summary).
  • Yaeshima T, Takahashi S, Matsumoto N, Ishibashi N, Hayasawa H, Iino H. 1997. Effect of yogurt containing Bifidobacterium longum BB536 on the intestinal environment, fecal characteristics and defecation frequency: a comparison with standard yogurt. Biosci Microflora. 16:73–77.
  • Yang Y, He M, Hu G, Wei J, Pages P, Yang X, Bourdu-Naturel S. 2008. Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated woman. World J Gastroenterol. 28:6237–6243.
  • Yogo T, Ohashi Y, Terakado K, Harada Y, Nezu Y, Hara Y, . 2011. Influence of dried okara-tempeh on the composition and metabolites of fecal microbiota in dogs. Int J Appl Res Vet Med. 9:181–188.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.